2017
DOI: 10.1080/14764172.2017.1383613
|View full text |Cite
|
Sign up to set email alerts
|

Photobiomodulation therapy for androgenetic alopecia: A clinician’s guide to home-use devices cleared by the Federal Drug Administration

Abstract: AGA, androgenetic alopecia; FDA, Food and Drug Administration; IEC, International Electrotechnical Commission; LED, light-emitting diode; PBMT, photobiomodulation therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
22
0
6

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(28 citation statements)
references
References 40 publications
0
22
0
6
Order By: Relevance
“…The efficacy of PDT for the treatment of hair loss is reported in several published studies [ 117 ]. Main reported evidence refers to LLLT as the most used light source [ 118 120 ].…”
Section: Introductionmentioning
confidence: 99%
“…The efficacy of PDT for the treatment of hair loss is reported in several published studies [ 117 ]. Main reported evidence refers to LLLT as the most used light source [ 118 120 ].…”
Section: Introductionmentioning
confidence: 99%
“…It is imperative to reassure parents of the benign nature of the disease and provide realistic expectations that these children will not spontaneously grow long hair in the future. Photobiomodulation can be a safe option that could be tried in the future …”
Section: Discussionmentioning
confidence: 99%
“…LLLT has become widely popular due to commercially available devices that can be used at home, are of low cost, are easy to navigate, and have a great safety profile. To date, there are 29 FDA cleared devices for the treatment of pattern hair loss in males, females, or both [14]. LLLT has biostimulatory effects on tissues and is presumed to prolong anagen (growth phase), stimulate anagen reentry from telogen (resting phase), and inhibit early transition to catagen (regression phase) [9, 15, 16].…”
Section: Introductionmentioning
confidence: 99%